Stockscreener 앱 받기
71.20
2.02%
1.41
시장 영업 전:
71.23
0.03
+0.04%
전일 마감가:
$69.79
열려 있는:
$70.125
하루 거래량:
12.77M
Relative Volume:
0.91
시가총액:
$105.65B
수익:
$20.08B
순이익/손실:
$2.89B
주가수익비율:
36.72
EPS:
1.9391
순현금흐름:
$3.66B
1주 성능:
+1.77%
1개월 성능:
-6.67%
6개월 성능:
-27.72%
1년 성능:
-28.01%
1일 변동 폭
$70.10
$71.91
1주일 범위
$67.56
$71.91
52주 변동 폭
$67.56
$109.50
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
71.20 | 103.56B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
ABT
Abbott Laboratories
|
110.71 | 191.06B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
349.11 | 133.77B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
88.44 | 113.29B | 35.48B | 4.64B | 5.41B | 3.582 |
|
EW
Edwards Lifesciences Corp
|
84.27 | 48.53B | 6.07B | 1.06B | 1.34B | 1.8063 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-03 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-09-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-04-16 | 업그레이드 | Needham | Hold → Buy |
| 2025-01-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
CIBC Bancorp USA Inc. Makes New $59 Million Investment in Boston Scientific Corporation $BSX - MarketBeat
Avity Investment Management Inc. Takes Position in Boston Scientific Corporation $BSX - MarketBeat
Danica Pension Livsforsikringsaktieselskab Acquires New Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Financial Times
Boston Scientific (BSX): UBS Lowers Price Target to $105 | BSX S - GuruFocus
BSX Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline in Boston Scientific Corporation Securities Class Action Lawsuit -- The Gross Law Firm – Company AnnouncementFT.com - Financial Times
Lombard Odier Asset Management USA Corp Acquires New Shares in Boston Scientific Corporation $BSX - MarketBeat
National Bank of Canada FI Grows Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Jain Global LLC Decreases Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Purchased by Focus Partners Wealth - MarketBeat
Drug Eluting Balloon Market Market Poised Boom | Boston Scientific Corporation, BD, Terumo Corporation - openPR.com
BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit - Financial Times
Jefferies reiterates Boston Scientific stock rating on growth outlook - Investing.com
BSX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 – Company Announcement - Financial Times
Boston Sci’s Rezūm therapy superior to drugs in treating BPH - BioWorld MedTech
INVESTOR NOTICE: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - Business Wire
Boston Scientific Lawsuits Put Electrophysiology Outlook And Valuation In Focus - Yahoo Finance
Holocene Advisors LP Sells 2,706,169 Shares of Boston Scientific Corporation $BSX - MarketBeat
Alliancebernstein L.P. Decreases Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Is Boston Scientific Corp. (BSX) Pull Back Overdone as Financial Results Impress? - Insider Monkey
BSX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
BSX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 (2026-03-15) - Seeking Alpha
Boston Scientific Corporation $BSX Holdings Lifted by Capitolis Liquid Global Markets LLC - MarketBeat
California Public Employees Retirement System Cuts Stock Position in Boston Scientific Corporation $BSX - MarketBeat
BNP Paribas Has $9.43 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
Aquatic Capital Management LLC Buys New Shares in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific stock hits 52-week low at 68.19 USD By Investing.com - Investing.com Nigeria
Assessing Boston Scientific (BSX) Valuation After Recent Penumbra Acquisition And Share Price Weakness - Yahoo Finance
INVESTOR DEADLINE: Snowflake Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law - GlobeNewswire Inc.
INVESTOR DEADLINE: Boston Scientific Corporation Investors - GlobeNewswire
Ossiam Lowers Holdings in Boston Scientific Corporation $BSX - MarketBeat
Prosight Management LP Buys Shares of 76,100 Boston Scientific Corporation $BSX - MarketBeat
iSAM Funds UK Ltd Invests $1.47 Million in Boston Scientific Corporation $BSX - MarketBeat
Main Street Research LLC Sells 374,847 Shares of Boston Scientific Corporation $BSX - MarketBeat
Integral Health Asset Management LLC Trims Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Purchased by Banque Transatlantique SA - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Boston Scientific Corporation $BSX Shares Sold by Tocqueville Asset Management L.P. - MarketBeat
Sei Investments Co. Has $224 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Entropy Technologies LP Has $6.37 Million Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Bought by Arrowstreet Capital Limited Partnership - MarketBeat
BSX News | BOSTON SCIENTIFIC CORP (NYSE:BSX) - ChartMill
Why Boston Scientific (BSX) Dipped More Than Broader Market Today - Yahoo Finance
INVESTOR NOTICE: Boston Scientific Corporation Investors with Su - GuruFocus
Boston Scientific stock hits 52-week low at 68.19 USD - Investing.com South Africa
INVESTOR NOTICE: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
BSX INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - Barchart.com
BSX Lawsuit Alleges Claims Executives Misrepresented U.S. Electrophysiology VolumesBOSTON SCIENTIFIC CORPORATION Investors Face Losses Following Claims Executives Misrepresented U.S. Electrophysiology Volumes: SueWallSt - Stock Titan
Boston Scientific Corp (NYSE:BSX): A GARP Stock with Strong Growth and Reasonable Valuation - ChartMill
Rep. Gilbert Ray Cisneros, Jr. Buys Boston Scientific Corporation (NYSE:BSX) Stock - MarketBeat
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.23%
0.13%
자본화:
|
볼륨(24시간):